Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Nano Pharmaceuticals Labs Partners with PLT Health Solutions to Expand its zümXR Targeted Release Ingredients Globally
PLT Health Solutions announced that it has partnered with Nano Pharmaceuticals Labs to market its […]
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics
Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on […]
Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients
Tubulis and Bristol Myers Squibb today announced that they have entered into a strategic license […]
Asahi Kasei Bioprocess America and GeminiBio Enter Strategic Partnership
Asahi Kasei Bioprocess America, a subsidiary of diversified Japanese multinational company Asahi Kasei, and GeminiBio […]
Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines […]
Daewoong Pharmaceutical and Sygnature Discovery Announce Drug Discovery Research Collaboration
Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open […]
MapKure, BeiGene and SpringWorks Present Clinical Data on BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors
MapKure, BeiGene and SpringWorks Therapeutics, today announced that they will present updated clinical data from the […]
Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSite
Lipella Pharmaceuticals, a clinical-stage biotechnology company addressing serious diseases with significant unmet need, has entered […]
Ginkgo Bioworks and WARF Announce Partnership to Discover Next Generation GD2 CAR T-Cell Therapies
The Wisconsin Alumni Research Foundation (WARF), which has a mission of supporting research at the University […]
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more